A most recent follow-up study by Pido-Lopez et al. demonstrated that systemic injection of etanercept, a TNFα inhibiting drug, dampens the plasma level of TNFα and other peripheral circulating proinflammatory cytokines such as IL1β and IL6 in preclinical HD R6/2 transgenic mice. The gene discussed is TNF; the disease is Huntington disease.